Covered recipient · General Payments record
JONATHAN S JACOBS
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$6,852.45
- Reported across 231 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $494.79 | 27 |
| Long term medical supply or device loan | $325.80 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $353.34 | 19 |
| Integra LifeSciences Corporation | $338.28 | 2 |
| Galderma Laboratories, L.P. | $57.77 | 3 |
| REVANCE THERAPEUTICS, INC. | $49.45 | 3 |
| ETS Wound Care LLC | $21.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.97 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979904 | CMS |
| ABBVIE INC. | $17.67 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979906 | CMS |
| ABBVIE INC. | $20.95 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979908 | CMS |
| ABBVIE INC. | $11.92 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979910 | CMS |
| ABBVIE INC. | $23.02 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979912 | CMS |
| ABBVIE INC. | $27.47 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979914 | CMS |
| ABBVIE INC. | $23.62 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979916 | CMS |
| ABBVIE INC. | $17.51 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979918 | CMS |
| ABBVIE INC. | $22.25 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979920 | CMS |
| ABBVIE INC. | $5.86 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979922 | CMS |
| ABBVIE INC. | $20.87 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979924 | CMS |
| ABBVIE INC. | $6.66 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979926 | CMS |
| ABBVIE INC. | $25.36 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979928 | CMS |
| ABBVIE INC. | $21.92 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979930 | CMS |
| ABBVIE INC. | $7.06 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979932 | CMS |
| ABBVIE INC. | $22.27 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979934 | CMS |
| ABBVIE INC. | $19.23 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979936 | CMS |
| ABBVIE INC. | $13.09 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979938 | CMS |
| ABBVIE INC. | $23.64 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979940 | CMS |
| ETS Wound Care LLC | $21.75 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150191888 | CMS |
| Galderma Laboratories, L.P. | $20.22 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145306211 | CMS |
| Galderma Laboratories, L.P. | $22.02 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145306213 | CMS |
| Galderma Laboratories, L.P. | $15.53 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145306215 | CMS |
| Integra LifeSciences Corporation | $325.80 | 09/11/2024 | Long term medical supply or device loan | Undisputed | 01/23/2026 | 1140106515 | CMS |
| Integra LifeSciences Corporation | $12.48 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140106511 | CMS |
| REVANCE THERAPEUTICS, INC. | $15.95 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147920878 | CMS |
| REVANCE THERAPEUTICS, INC. | $20.25 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147920880 | CMS |
| REVANCE THERAPEUTICS, INC. | $13.25 | 07/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147920882 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.